Banner

Meningococcal Vaccines Global Market Report 2023 – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Children, Adolescents and Young Adults, Adults), By Distribution Channel: (Pharmacies, Community Clinics, Public Health Agencies, Other Channels), By End user (Hospitals, Research, Academic Institutes) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


Meningococcal vaccinations are vaccines that protect against meningococcal meningitis, an infection with the bacterium Neisseria meningitides that leads to inflammation of the tissues that surround the brain and spinal cord.

The main types of meningococcal vaccines are meningococcal conjugate vaccine, polysaccharide vaccine, and subcapsular vaccine. Meningococcal conjugate vaccine refers to a compound made up of a polysaccharide antigen fused (conjugated) to a carrier molecule. The different serotypes include Men ACWY, Men B/Bc, and Men C, given to various age groups such as infants, children, adolescents, young adults, and adults, and distributed by pharmacies, community clinics, public health agencies, and others. These are used by various end-users, such as hospitals, research institutions, and academic institutes.

The meningococcal vaccines market research report is one of a series of new reports from The Business Research Company that provides meningococcal vaccines market statistics, including the meningococcal vaccines industry's global market size, regional shares, competitors with a meningococcal vaccines market share, detailed meningococcal vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the meningococcal vaccines industry. The meningococcal vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global meningococcal vaccines market size is expected to grow from $3.21 billion in 2022 to $3.53 billion in 2023 at a compound annual growth rate (CAGR) of 10%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The meningococcal vaccines market size is expected to grow to $5.09 billion in 2027 at a CAGR of 9.6%.

An increase in healthcare spending is expected to propel the growth of the meningococcal vaccine market going forward. Healthcare refers to a residential care institution, nursing facility, intermediate care facility for people with mental illnesses, or intermediate care facility for people with mental retardation. The high expense of new vaccine generations compared to their predecessors has become a key factor in discussions about whether the benefits of the new vaccinations justify their prices. Assessing the complete social and economic advantages of vaccination is becoming an increasingly important area of investigation in the literature on valuing vaccination. For instance, in May 2022, according to an article published by the American Medical Association, a US-based professional association and lobbying group of physicians and medical students, healthcare spending in the United States had risen by 9.7% to $4.1 trillion, or $12,530 per person. This pace of growth is significantly higher than 2019's (4.3%). Therefore, an increase in healthcare spending is driving the growth of the meningococcal vaccine market.

Product innovation is a key trend in the meningococcal vaccine market. Major players operating in the meningococcal vaccines market are creating innovative new items using cutting-edge technology to maintain their position in the meningococcal vaccines market. For instance, in April 2020, Sanofi Pasteur Inc., a France-based life-protecting vaccines company, received Food and Drug Administration (FDA) approval for the usage of menquadfi by those who are at least 2 years old. Menquadfi helps to prevent the spread of invasive meningococcal illnesses (including meningitis) caused by the bacteria N meningitides serogroups A, C, W, and Y. The initial and single quadrivalent meningococcal strains are called MenQuadfi vaccinations. It employs tetanus toxoid as a protein carrier and is accessible in a ready-to-use liquid format, eliminating the need for healthcare personnel to reconstitute the vaccine.

In August 2022, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, acquired Affinivax Inc. for $3.3 billion. The acquisition of Affinivax is consistent with GSK's aim of establishing a robust portfolio of specialty medicines and vaccines. Affinivax, Inc., is a US-based next-generation vaccine technology company operating in the meningococcal vaccines market.

Major players in the meningococcal vaccines market are Pfizer Inc., Novartis AG, Sanofi S.A., Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Incepta Pharmaceuticals Ltd., Bio-Med Limited, Walvax Biotechnology Co., Ltd., Bio-Manguinhos, Hualan Biological Engineering Inc., JN-International Medical Corporation, Johnson & Johnson, AstraZeneca plc, and Bavarian Nordic A/S.

North America was the largest region in the meningococcal vaccines market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the meningococcal vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the meningococcal vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The meningococcal vaccines market consists of sales of conjugate vaccines, combination vaccines, serogroup B vaccine products, and other types. Values in this market are ‘pharmaceuticals’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global meningococcal vaccines market is segmented -

1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine

2) By Serotype: Men Acwy, Men B/Bc, Men C

3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults

4) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Channels

5) By End user: Hospitals, Research, Academic Institutes

    Table Of Contents

    1. Executive Summary

    2. Meningococcal Vaccines Market Characteristics

    3. Meningococcal Vaccines Market Trends And Strategies

    4. Meningococcal Vaccines Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Meningococcal Vaccines Market

    4.2. Ukraine-Russia War Impact On Meningococcal Vaccines Market

    4.3. Impact Of High Inflation On Meningococcal Vaccines Market

    5. Meningococcal Vaccines Market Size And Growth

    5.1. Global Meningococcal Vaccines Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Meningococcal Vaccines Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Meningococcal Vaccines Market Segmentation

    6.1. Global Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Meningococcal Conjugate Vaccine

    Polysaccharide

    Subcapsular Vaccine

    6.2. Global Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Men Acwy

    Men B/Bc

    Men C

    6.3. Global Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Infants

    Children

    Adolescents and Young Adults

    Adults

    6.4. Global Meningococcal Vaccines Market, Segmentation By Distribution Channel:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Pharmacies

    Community Clinics

    Public Health Agencies

    Other Channels

    6.5. Global Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Research

    Academic Institutes

    7. Meningococcal Vaccines Market Regional And Country Analysis

    7.1. Global Meningococcal Vaccines Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Meningococcal Vaccines Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Meningococcal Vaccines Market

    8.1. Asia-Pacific Meningococcal Vaccines Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Meningococcal Vaccines Market

    9.1. China Meningococcal Vaccines Market Overview

    9.2. China Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Meningococcal Vaccines Market

    10.1. India Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Meningococcal Vaccines Market

    11.1. Japan Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Meningococcal Vaccines Market

    12.1. Australia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Meningococcal Vaccines Market

    13.1. Indonesia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Meningococcal Vaccines Market

    14.1. South Korea Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Meningococcal Vaccines Market

    15.1. Western Europe Meningococcal Vaccines Market Overview

    15.2. Western Europe Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Meningococcal Vaccines Market

    16.1. UK Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Meningococcal Vaccines Market

    17.1. Germany Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Meningococcal Vaccines Market

    18.4. France Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Meningococcal Vaccines Market

    19.1. Eastern Europe Meningococcal Vaccines Market Overview

    19.2. Eastern Europe Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Meningococcal Vaccines Market

    20.1. Russia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Meningococcal Vaccines Market

    21.1. North America Meningococcal Vaccines Market Overview

    21.2. North America Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Meningococcal Vaccines Market

    22.1. USA Meningococcal Vaccines Market Overview

    22.2. USA Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Meningococcal Vaccines Market

    23.1. South America Meningococcal Vaccines Market Overview

    23.2. South America Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Meningococcal Vaccines Market

    24.1. Brazil Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Meningococcal Vaccines Market

    25.1. Middle East Meningococcal Vaccines Market Overview

    25.2. Middle East Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Meningococcal Vaccines Market

    26.1. Africa Meningococcal Vaccines Market Overview

    26.2. Africa Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Meningococcal Vaccines Market Competitive Landscape And Company Profiles

    27.1. Meningococcal Vaccines Market Competitive Landscape

    27.2. Meningococcal Vaccines Market Company Profiles

    27.2.1. Pfizer Inc

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Novartis AG

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Sanofi S.A

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Serum Institute of India Pvt. Ltd

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. GlaxoSmithKline plc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Meningococcal Vaccines Market

    29. Meningococcal Vaccines Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Meningococcal Vaccines Market, Segmentation By Distribution Channel:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Meningococcal Vaccines Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Global Meningococcal Vaccines Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: China, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: India, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Japan, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Australia, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: Indonesia, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South Korea, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Western Europe, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: UK, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: Germany, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: France, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Eastern Europe, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: Russia, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: North America, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: USA, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: South America, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Brazil, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Middle East, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Africa, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 48: Pfizer Inc Financial Performance
  • Table 49: Novartis AG Financial Performance
  • Table 50: Sanofi S.A Financial Performance
  • Table 51: Serum Institute of India Pvt. Ltd Financial Performance
  • Table 52: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Meningococcal Vaccines Market, Segmentation By Distribution Channel:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Meningococcal Vaccines Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Global Meningococcal Vaccines Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: China, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: India, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Japan, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Australia, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: Indonesia, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South Korea, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Western Europe, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: UK, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: Germany, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: France, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Eastern Europe, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: Russia, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: North America, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: USA, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: South America, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Brazil, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Middle East, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Africa, Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 48: Pfizer Inc Financial Performance
  • Figure 49: Novartis AG Financial Performance
  • Figure 50: Sanofi S.A Financial Performance
  • Figure 51: Serum Institute of India Pvt. Ltd Financial Performance
  • Figure 52: GlaxoSmithKline plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report